Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4
Conditions
Brief summary
The aim of the present study is to assess the post-operative outcomes (morbidity and mortality) in relation to preoperative data and the oncological outcomes (overall and disease-free survival) in patients with a locally advanced colon cancer (LACC) with the necessity of a multivisceral resection (MVR).
Detailed description
All patients that meet the inclusion criteria will be registered in a retrospective database from 2014 to 2019 (5 years) Data will be reported for every patients with colon cancer to have had either a resection of another organ or structure in addition to resection of the primary tumor, or to have had a T4 (a or b) tumour on postoperative histopathology. Data included are patient demographics, ASA score, tumor localization, preoperative imaging, neoadjuvant treatments, type of bowel resection and adjacent organs resected, tecnique (laparoscopic/laparotomic), postoperative complications and 30-day mortality, histopathology data including TNM scoring, completeness of surgical procedure (R0 to R2) and infiltration of tumor cells in resected tissues, adjuvant oncological treatments, and long term follow-up data on local and distant recurrence and survival.
Interventions
Multivisceral resection for locally advanced colon cancer.
Sponsors
Study design
Eligibility
Inclusion criteria
* \> 18 aa * Patients with a locally advanced colon cancer (LACC) with the necessity of a multivisceral resection (MVR).
Exclusion criteria
* Stage IV * Rectal cancer * Emergency surgery (\<48 hours from admission) * ASA \> III
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative morbidity | 30 days | I evaluate peri and post-operative surgical (e.g. intraabdominal collection, fistula, anastomotic leak) and medical (e.g. pneumoniae, deep vein thrombosis) complications |
| Postoperative mortality | 30 days | I evaluate in-hospital and 30-day mortality correlate to the intervention |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Overall Survival | 5 years | The length of time from the intervention that patients diagnosed with a T4 colon cancer are still alive. |
| Disease Free Survival | 5 years | The measure of time after treatment during which no sign of recurrence (local or metastatic) is found. |